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Abstract Ras-associated binding (Rab) proteins and Rab-
associated proteins are key regulators of vesicle transport,
which is essential for the delivery of proteins to specific
intracellular locations. More than 60 human Rab proteins
have been identified, and their function has been shown to
depend on their interaction with different Rab-associated
proteins regulating Rab activation, post-translational modifi-
cation and intracellular localization. The number of known
inherited disorders of vesicle trafficking due to Rab cycle
defects has increased substantially during the past decade.
This review describes the important role played by Rab
proteins in a number of rare monogenic diseases as well as
common multifactorial human ones. Although the clinical
phenotype in these monogenic inherited diseases is highly
variable and dependent on the type of tissue in which the
defective Rab or its associated protein is expressed, frequent
features are hypopigmentation (Griscelli syndrome), eye
defects (Choroideremia, Warburg Micro syndrome and
Martsolf syndrome), disturbed immune function (Griscelli
syndrome and Charcot–Marie–Tooth disease) and neurolog-
ical dysfunction (X-linked non-specific mental retardation,
Charcot–Marie–Tooth disease, Warburg Micro syndrome
and Martsolf syndrome). There is also evidence that
alterations in Rab function play an important role in the
progression of multifactorial human diseases, such as infec-
tious diseases and type 2 diabetes. Rab proteins must not
only be bound to GTP, but they need also to be
‘prenylated’—i.e. bound to the cell membranes by isoprenes,
which are intermediaries in the synthesis of cholesterol (e.g.
geranyl geranyl or farnesyl compounds). This means that
isoprenylation can be influenced by drugs such as statins,
which inhibit isoprenylation, or biphosphonates, which inhibit
that farnesyl pyrophosphate synthase necessary for Rab
GTPase activity. Conclusion: Although protein-trafficking
disorders are clinically heterogeneous and represented in
almost every subspeciality of pediatrics, the identification of
common pathogenic mechanisms may provide a better
diagnosis and management of patients with still unknown
Rab cycle defects and stimulate the development of thera-
peutic agents.
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Abbreviations
AQP2 aquaporin 2
AVP antidiuretic hormone vasopressin
CHM choroideremia
CMT Charcot–Marie–Tooth
CTL cytotoxic T lymphocytes
ER endoplasmic reticulum
GAP GTPase-activating protein
GDI GDP-dissociation inhibitor
GEF guanine nucleotide-exchange factor
GLUT4 glucose transporter 4
GS Griscelli syndrome
HSAN hereditary sensory and autonomic neuropathies
IFNγ interferon gamma
MAPK mitogen-activated protein kinase
NDI nephrogenic diabetes insipidus
Rab Ras-associated binding protein
RabGGT Rab geranylgeranyl transferase
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Introduction
Germline mutations in the genes involved in the Ras–
mitogen-activated protein kinase (MAPK) pathway explain
a number of neuro–cardio–facio–cutaneous syndromes, as
reported in a paper recently published in this journal [10].
Ras-associated binding (Rab) proteins are small GTPases
of the Ras superfamily that continuously cycle between the
cytosol and different membranes. In 2002, Pfeffer described
20 different Rab GTPases that have been identified as
prenylated proteins localized in distinct membrane-bound
compartments [25]. Prenylated proteins are proteins bound
to isoprenes, which are intermediaries in the cholesterol
synthesis. At the time of the writing this article, more than
60 human Rabs had been identified [26]. This high number
of different Rab proteins highlights their importance in the
regulation of vesicle trafficking processes, including vesicle
formation, motility, tethering and fusion to the acceptor
membrane and signaling to other organelles. The ability of
Rabs to perform these different tasks in a co-ordinated and
regulated manner originates in their highly dynamic
conformation and mobility and from their interaction with
different Rab-associated proteins, as illustrated in the Rab
GTPase cycle (Fig. 1). Rabs can cycle between the active
GTP-bound and the non-active GDP-bound forms, assisted
by different Rab-associated proteins, such as the GEFs
Fig. 1 The Ras-associated binding (Rab) protein–GTPase cycles. Rab
proteins are intrinsically soluble and require a post-translational
modification for membrane association. They first associate with a
Rab escort protein (REP) and form a stable complex that is the
substrate for the subsequent dual prenylation of C-terminal cysteine
motifs via Rab geranylgeranyl transferase (RabGGT). RabGGT
consists of two different functional subunits (RabGGTα and
RabGGTß). After lipid tranfer, REP delivers the prenylated Rab to
the donor membrane (the REP cycle is shown with blue arrows). In
the absence of REP or RabGGT, Rab proteins remain in the cytosol in
an inactive state. The transfer of Rab proteins between acceptor and
donor membranes is facilitated by the GDP dissociation inhibitor
(GDI) (the GDI cycle is shown with red arrows). Both REP and GDI
bind the GDP-bound inactive form of Rab. After REP or GDI
dissociate from Rabs at the donor membrane, Rabs can cycle between
the inactive (GDP-bound) and active (GTP-bound) states. Rab
proteins are activated by guanine nucleotide exchange factors
(RabGEFs) and deactivated by GTPase activating proteins (Rab-
GAPs), which accelerate the slow intrinsic rates of nucleotide
exchange and GTP hydrolysis. In the active state, Rabs interact with
structurally and functionally diverse effectors, including cargo sorting
complexes on donor membranes, motor proteins involved in vesicular
transport and tethering complexes that regulate vesicle fusion with
acceptor membranes
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activating proteins), respectively [24, 26]. This conforma-
tional cycle is the main driving force for the on/off ‘switch’
mechanism of Rabs and their ability to both regulate
binding to downstream effectors and perform the desired
function. Rabs are initially synthesized as soluble proteins
in the cytosol where they are first recognized by a soluble
chaperone-like protein named REP (Rab escort protein) [3].
The REP brings the Rab to the RabGGT (Rab geranylger-
anyl transferase) for the addition of—generally—two
geranylgeranyl groups. These prenyl groups are added, by
covalent thioether bonds, to cysteine residue(s) located at
the C-terminus of the Rab protein [7]. This post-transla-
tional modification of Rabs is needed to allow for the
attachment of the Rab proteins into the lipid bilayer of the
organelle; consequently, Rabs are considered to be periph-
eral membrane proteins (Fig. 1). After performing their
function, Rab proteins are extracted from the membranes by
RabGDI (GDP dissociation inhibitor), and they remain in
the cytosol until they are needed again [7, 24, 37]. Statins
are known to inhibit protein isoprenylation. As such, they
are able to reduce the production of amyloid-beta and
inhibit preamyloid catabolism in the lysosomes, which
suggests their possible application in the treatment of
Alzheimer [20]. However, the therapeutic role of statins in
Rab-related disorders has not yet been established. The
potent nitrogen-containing biphosphonates, such as pamidr-
onate, alendronate, ibandronate and zoledronate, inhibit a
key enzyme, farnesyl pyrophosphate synthase, which is
necessary for Rab activity, hence their inhibitory action on
osteoclast activity [29].
Evolutionarily conserved Rabs are usually expressed in
all cell and tissue types and regulate more fundamental
vesicle transport pathways whereas the less conserved Rab
family members function in more specific pathways, which
are often organ-dependent. Defects in intracellular vesicle
trafficking underlie a large variety of human diseases,
including pathologies associated with defects in Rabs or
Rab-associated proteins [14, 32]. In this review, we deal
with the role of different Rab and rab-associated proteins in
inherited (Table 1) as well as certain multifactorial human
diseases in different pediatric disciplines. In addition, the
review will also focus briefly on recent advances in
understanding human disease through the study of Rab
proteins from in vitro and mouse knockout studies.
Rab proteins in skin and hear pigmentation
Griscelli syndrome (GS) is an autosomal recessive disorder
that causes partial albinism [15]. There are three variants of
this disease: one is a purely hypopigmentation disorder (GS
type III), and two, in addition to the pigmentation defect,
are also associated with immunological defects (GS type II)
or with primary neurological dysfunctions (GS type I).
Griscelli syndrome type II with immunological defects is
caused by missense mutations in the gene encoding Rab27a
[18]. This Rab regulates the movement of melanosomes to
the cell periphery of melanocytes and also regulates the
secretion of lytic granules in cytotoxic T lymphocytes
(CTL) [35]. The lack of Rab27a thus causes pigment
anomalies and dysfunctional T lymphocytes, which is in
agreement with the defects observed in the patients that
present with albinism and hemophagocytic syndrome. The
GS type I with neurological symptoms is caused by
mutations in the MYO5A gene encoding the motor protein
myosin Va [22], a putative Rab27a effector that drives the
peripheral distribution of melanosomes along actin fila-
Table 1 Human monogenic diseases caused by a Ras-associated binding (Rab) protein or Rab-associated protein defect
Disease OMIM Gene Rab Rab-associated Description
Griscelli syndrome type I 214450 MYO5A x Autosomal recessive, albinism, neurological impairment
Griscelli syndrome type II 607624 RAB27A x Autosomal recessive, albinism, hemophagocytic syndrome,
sometimes secondary neurological impairment
Griscelli syndrome type III 609227 MLPH x Autosomal recessive, albinism
Choroideremia 303100 REP1 x X-linked, progressive loss of vision beginning at an early
age, and the choroid and retina undergo complete atrophy
Non-specific mental
retardation
300104 GDI1 x X-linked, affected males show moderate to severe mental
retardation, carrier females may also be mildly affected
Charcot-Marie-Tooth
disease type IIb
608882 RAB7 x Autosomal dominant, peripheral sensory neuropathy with
late onset muscle weakness, foot ulcers and infections
Warburg Micro syndrome 600118 RAB3GAP1 x Autosomal recessive, microcephaly, microcornea,
congenital cataract, mental retardation, optic atrophy,
and hypogenitalism
Martsolf syndrome 212720 RAB3GAP2 x Autosomal recessive, congenital cataracts, hypogonadism,
and mild mental retardation
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exocytosis of lytic granules of CTL, the inactivation of this
protein does not lead to immunological symptoms. Finally,
GS type III in patients with typically pigment abnormalities
without additional features is caused by a mutation in the
MLPH gene encoding melanophilin. A direct interaction
exists between the SHD domain of melapholin and Rab27a
and between the C-terminal domain of melanophilin and
myosin Va [36]. Therefore, although the Rab27a/Mlph/
MyoVa complex is crucial for the trafficking of melano-
somes, neurodevelopmental abnormalities are specific for
the Myo5a deficiency, and Rab27a uses a different effector
for its function in the CTL.
Rab proteins in immunology
It has already been mentioned that GS type II patients with
Rab27a mutations develop the hemophagocytic syndrome,
which is characterized by episodes of life-threatening
uncontrolled T lymphocyte and macrophage activation
[17]. During these episodes, activated T cells and macro-
phages infiltrate various organs (including the brain),
leading to tissue damage, organ failure and death in the
absence of immunosuppressive therapy. In practice, only
bone-marrow or cord blood stem cell transplantation can be
curative for this condition [33].
The important function of Rab proteins in intracellular
traffic, endocytosis and exocytosis explains their role in
counteracting bacterial and viral infections. Phagocytosis
by macrophages leads to the destruction of bacteria.
Endocytosis leads to the formation of phagosomes, but
phagosomes fuse with lysosomes (phagolysosomes), result-
ing in the release of toxic products that kill the bacterium as
well as the release of the degradation products by
exocytosis [19]. However, some bacteria survive this
process and avoid bactericide by escaping from the
phagosomes into the cytoplasm [19]. Listeria monocyto-
genes is a paramount example. It has been shown that the
stimulation of macrophages with interferon (IFN)-γ,a
cytokine that is secreted by natural killer and T helper
cells, results in the expression of at least 200 proteins,
including Rab5a [11]. In L. monocytogenes-infected macro-
phages, overexpression of Rab5a stimulates the intracellular
degradation of the pathogen [6]. It has been suggested that
Rab5a participates in the active recruitment of Rac2 to
phagolysosomes, which is important for the destruction of
the bacterium [27]. Other microbes develop antiphagocy-
tosis (e.g. Yersinia enterocolitica) or inhibit the formation
of phagosomes (e.g. Salmonella typhimurium). In Salmo-
nella infections, there is evidence that Rab5a is stabilized
on the phagosome by the Salmonella type III secretory
protein SopE [23]. SopE has GEF activity for Rab5a,
stimulating activated GTP-bound Rab5a and preventing its
membrane extraction by RabGDI. A general conclusion
that can be drawn is that parasites recruit endocytic Rabs to
prevent or delay the formation of the degradative phag-
olysosome in the host organism.
Viruses enter host cells by receptor-mediated endocyto-
sis, but they usually escape from endosomal vesicles to
enter either the cytosol or the nucleus where they replicate.
The binding of hepatitis C virus (HCV) non-structural
protein (NS) with Rab1 GTPase-activating protein suggests
that viruses are able to subvert host cell machinery in this
way because this binding is necessary for HCV replication.
Rab1 depletion decreases HCV-RNA levels, which could
lead to therapeutic applications [34].
Rab proteins in vision
Choroideremia is an X-linked disease that involves the
degeneration of the retinal pigment epithelium and the
adjacent choroid and retinal photoreceptor cell layers,
leading to blindness. The mutated gene in the choroider-
emia is one of the two REP isoforms, REP1 [3, 30].
Although the other isoform, REP-2, seems to be sufficient
for the geranylgeranylation of all Rab GTPases in all
tissues, the retinal pigment epithelium seems to be the
exception. A role for REP-2 in human disease has not yet
been discovered. REP-1 is essential for the efficient
geranylgeranylation of Rab27a in the retinal pigment
epithelium. Thus, a lack of REP1 leads to a lack of
functional Rab27a specifically in the retinal pigment
epithelium [30, 31]. The degeneration of this epithelium
and its adjacent layers may be due to deficient melanosome
transport and, consequently, a lack of protection against
harmful light exposure.
Rab proteins in neurology
A subgroup of patients with X-linked non-specific mental
retardation have mutations in the GDI1 gene for one of the
GDI isoforms, GDI-α [9]. This isoform is particularly
abundant in the brain, and dysfunctional membrane
recycling of one or more Rab GTPases in brain synapses,
leading to aberrant neurotransmission, is likely to underlie
the symptoms in this disease.
Hereditary sensory and autonomic neuropathies
(HSAN), known for many years as familial dysautonomia
in Jewish patients, are characterized by the loss of sensation
for pain and temperature, alacrima, excessive sweating and
the absence of fungiform tongue papillae. The onset is
congenital, and the transmission is autosomal recessive.
The clinical symptoms of HSAN have been classified into
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Charcot–Marie–Tooth disease type II. This is an axonal
neuropathy with a median motor conduction velocity of
>38 m/s. This peripheral neuropathy starts in the second or
third decade of life and presents as mixed motor and
sensory involvement associated with ulcers. Four mutations
in the Rab7 gene have been identified in four families with
Charcot–Marie–Tooth disease type 2B (CMT2B), with
symptoms leading to ulcerations and amputations [38, 39].
However, a hallmark feature of patients with HSAN type 1
is lancinating pain, which is not commonly observed in
CMT2B. Moreover, HSAN type 1 is associated with a
mutation in serine palmitoyl transferase (SPT), a rate-
limiting step in the sphingo-lipid synthesis. This over-
lapping of the two syndromes is possibly explained by
Rab7 being involved in both the endocytosis and transport
of sphingolipids [39].
The importance of Rab proteins in brain development
and function is even more emphasized by the recent
discoveries of the involvement of Rab3-associated proteins
in human disease [4, 5]. Rab3A is the most abundantly
expressed protein in the brain, where it is present in all
synapses and involved in calcium-dependent neurotrans-
mitter release [13]. The activity of Rab3 proteins is tightly
regulated by Rab3GAP, which specifically converts active
Rab3-GTP to the inactive-GDP form. Germline-inactivating
mutations in the catalytic subunit of Rab3GAP (Rab3-
GAP1) cause Warburg Micro syndrome, an autosomal
recessive disorder characterized by ocular defects (micro-
phthalmos, microcornea, congenital cataracts and optic
atrophy), neurodevelopmental defects (microcephaly, corti-
cal gyral abnormalities, such as pachygyria and polymicro-
gyria, hypoplasia of the corpus callosum, severe mental
retardation, and spastic cerebral palsy) and hypothalamic
hypogenitalism [4]. Mutations in the non-catalytic subunit
of Rab3GAP (Rab3GAP2) have been described in patients
with Martsolf syndrome, an autosomal recessive disorder
with a similar but milder phenotype than the Warburg
Micro syndrome, including congenital cataracts, hypogo-
nadism and mild mental retardation [5]. The precise
mechanisms whereby the Rab3GAP1 and Rab3GAP2
mutations cause the human phenotype is still unclear.
Rab proteins in endocrinology
Abnormal trafficking of the insulin-sensitive glucose
transporter GLUT4 has been described in patients with
diabetes type 2. Glucose transporter 4 accumulates in the
dense membrane compartments, suggesting that defects in
membrane trafficking may be involved in insulin resistance
[12]. Rab4 has been found to be implicated in GLUT4
biogenesis, sorting and exocytosolic movement but more
studies are needed to define the exact role of this and other
Rabs and Rab-associated proteins in GLUT4 trafficking
[16]. Rab4 mutations in humans or mice do not yet exist.
Rab27a is necessary for insulin secretion [2]. Diabetes
mellitus is characterized by both low insulin and high
glucagon levels. These conditions have been shown
recently to be due to the expression of an inducible cAMP
early repressor (ICER) [1], resulting in a repression of the
transcription of the insulin gene, and associated with a
Fig. 2 Regulation of aquaporin-
2( AQP2)-mediated water trans-
port by vasopressin (AVP).
Shown is a nephron with a
magnified principal cell. In this
cell, the vasopressin V2 receptor
(V2R), stimulatory GTP binding
protein (Gs), adenylate cyclase
(AC), ATP, cAMP, and phos-
phorylated proteins (O-P) are
indicated. This figure has been
used with permission of the
American Journal of Physiology
and Renal Physiology
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protein. However, patients with GS type II-homozygous
deficiency in Rab27a do not have diabetes mellitus.
The control of thyroid hormone production depends
on endocytic catalysts and the tandem regulators Rab5a
and Rab7, which have been found in excess in thyroid
adenomas [8].
Rab proteins in nephrology
Nephrogenic diabetes insipidus (NDI) is characterized by
the inability to concentrate the urine in response to the
antidiuretic hormone vasopressin (AVP). Under normal
conditions, binding of AVP to the vasopressin receptor
(V2R) leads to the insertion of aquaporin 2 (AQP2) water
channels in the apical membrane of the renal collecting duct
[28] (Fig. 2). The defect can be inherited and is either X-
linked due to mutations in the genes encoding the V2R or
autosomal recessive or dominant in mutations in the AQP2
gene. The trafficking of AQP2 in the cell and its inter-
nalization are cAMP and especially Rab11-dependent [40].
However, Rab11 mutations in humans or mice are not
yet described.
Conclusion
The Rab GTPases are a large family of proteins with a
variety of regulatory functions in membrane trafficking. The
central role of these proteins has become clear during the
past decade, as part of the progress that has been made in
understanding in detail the mechanistic principles of trans-
port vesicle formation, movement, and fusion. Sequencing of
the human genome has enabled researchers to realize the
diversity of the Rab gene family, although the functions of
the majority of the gene products are still unknown. The
availability of complete genomic sequences as well as the
important advances in molecular and cell biological methods
that have already been made hold the promise of significant
progress being booked in our understanding of Rab function
in the near future. The identification of further genes in-
volved not only in monogenic but also in common multi-
factorial human vesicle-trafficking disorders will result in a
better understanding of this complex transport pathway but,
more importantly, will also lead to opportunities to develop
novel treatments.
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